市場調查報告書

無針頭藥物遞輸系統的全球市場的考察與預測

Global Market Insights on Needle-Free Drug Delivery Systems: Insights and Forecast, 2018-2025: Emphasis on Product ; Technology ; Application ; Injection Mode ; Source of Power and Region

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 906180
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
無針頭藥物遞輸系統的全球市場的考察與預測 Global Market Insights on Needle-Free Drug Delivery Systems: Insights and Forecast, 2018-2025: Emphasis on Product ; Technology ; Application ; Injection Mode ; Source of Power and Region
出版日期: 2019年03月01日內容資訊: 英文 124 Pages
簡介

本報告提供全球無針頭 (不使用針頭的) 藥物遞輸系統市場相關調查分析,市場概要,各市場區隔的市場考察,競爭模式,主要企業等相關的系統性資訊。

第1章 市場簡介

第2章 調查手法/前提條件

第3章 法律規範和主要趨勢

第4章 業績

第5章 摘要整理

第6章 市場概要

  • 簡介
  • 市場動態
  • 市場課題
  • 市場機會

第7章 主要市場指標

  • 概要

第8章 市場考察:各產品類型

  • 概要
    • 預填充式 (已填充)
    • 可填充

第9章 市場考察:各技術

  • 概要
    • 噴氣式飛機式
    • 經皮
    • 吸入

第10章 市場考察:各應用類型

  • 概要
    • 胰島素輸送
    • 疫苗
    • 兒童用
    • 疼痛管理

第11章 市場考察:各注射方法

  • 概要
    • 粉末
    • 液體
    • Depot/Projectile Injection

第12章 市場考察:各動力

  • 概要
    • 發條式
    • 天然氣(氣體)
    • 電池

第13章 市場考察:各地區

  • 概要
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第14章 競爭模式

  • 波特的五力分析
  • 市場佔有率分析

第15章 主要企業簡介

  • Antares Pharma, Inc.
  • Consort Medical
  • Crossject Societe Anonyme
  • Inovio Pharmaceuticals
  • Injex Pharma
  • Medical International Technology
  • Zosano Pharma
  • Valeritas
  • 3M
  • PharmaJet
目錄
Product Code: UMHE19139

Needle free injection system provides solution of introducing several drugs into the host body without piercing the skin with a hypodermic needle. Needle free drug delivery devices are used worldwide by diabetes patients to administer insulin in their bodies. Increasing cases of chronic diseases such as Dengue, AIDS, and Hepatitis among others have also grown globally. Therefore, the steady growth in chronic diseases has also added to the overall demand for needle free drug delivery devices majorly in the developed and developing countries such as US, Germany, Japan, and China among others. Increasing prevalence's of chronic diseases such as diabetes, hypertension and cancer, would further drive the global needle free drug delivery device market. According to the WHO, Cancer is one of the leading cause of deaths across the globe. In 2018, 9.6 million deaths occurred due to Cancer. According to the National Cancer Institute, an estimated 1,735,350 new cases of Cancer are diagnosed in the United States and 609,640 people died from the disease in 2018. Needle-free injection offers an advance and effective route for administration drugs without pain.

Adding further, rising demand to prevent and minimize the effect of needle-stick injuries are also projected to drive the overall demand for the needle free drug delivery devices. Needlestick and sharp injuries can result in the transmission of infectious diseases particularly bloodborne viruses such as HIV, hepatitis B and hepatitis C, among others. The escalation of producing and modeling of the needle free drug delivery devices is expanding due to the inclination of population towards the use of easy, safe and home care drug delivery medical devices. The needle free drug delivery products can be classified based on type such as self-injectors, needle-free injectors and auto-injectors. The needle technology used in this market includes pen-needle and micro-needle. The micro-needle patches have some economic and practical restraints.

Owing to the substantial promotional packages of government plans, the needle-free drug delivery system market is anticipated to propel in the years to come. The global needle free drug delivery market is expected to grow at a CAGR of 10% during the forecast period of 2018- 2025, to reach a market size of US$ xx billion in 2025. Based on the products prefilled, needle-free injection system dominates the market with the revenue share of XX% in 2018. Fillable needle-free injection system was the second most preferred product category available in the market. Based on technology, jet injectors dominated the market in 2018. Jet injectors technology segment is expected to grow at a CAGR of XX% during the forecast period 2018-2025 to reach a market size of US$ XX billion by 2025. However, transdermal drug delivery technology system is expected to witness highest CAGR growth during the analyzed period. Insulin delivery, vaccinations, pediatric injections and pain management are the major application of needle free drug delivery system, insulin delivery being the most prominent application of the technology, owing to the increased prevalence's of diabetes in developed as well as developing countries.

In addition, needle free drug devices are segmented by types of injection methods. The system is designed to inject drug into skin, tissues and muscles using solid and liquid dosages. The liquid injections are expected to grow at the highest rate XX% during the forecast period 2018-2025. Apart from this, Powder Injections constitute the second largest market. Furthermore, needle-free drug devices use power sources such as spring load jet Injector system, gas powdered jet injector and battery powdered jet injector system. The gas powdered jet injector system holds major share in the market with the revenue share of XX% in 2018.

Table of Contents

1. MARKET INTRODUCTION

  • 1.1 Market Definition 12
  • 1.2 Objective of the Study 12
  • 1.3 Limitation 12
  • 1.4 Stakeholders 13
  • 1.5 Currency used in the Report 13

2. RESEARCH METHODOLOGY OR ASSUMPTION 14

  • 2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
    • 2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15

3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16

  • 3.1 General Overview 16
    • 3.1.1 North America 16
    • 3.1.2 Europe 17

4. INDUSTRY PERFORMANCE 18

5. EXECUTIVE SUMMARY 20

6. MARKET OVERVIEW 23

  • 6.1 Introduction 23
  • 6.2 Market Dynamics 24
    • 6.2.1 Market Trend & Drivers 24
    • 6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24
    • 6.2.3 Inclination Towards Self Administration of Drugs 26
    • 6.2.4 Growing Technological Advancements in the Devices 27
  • 6.3 Market Challenges 27
    • 6.3.1 Ambiguity in the Specifications of Needle Free Devices 27
    • 6.3.2 Limitations associated with Micro Needle Patches 28
  • 6.4 Market Opportunities 28
    • 6.4.1 Increase in the number of start-ups and Investments 28
    • 6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30

7. KEY MARKET INDICATORS 31

  • 7.1 General Overview 31
    • 7.1.1 Demand and Supply Side Analysis 31
      • 7.1.1.1 Top Winning Strategies 32
        • 7.1.1.1.1 Top Product launches 32
        • 7.1.1.1.2 Top Business Expansions & Investments 33
        • 7.1.1.1.3 Top Acquisition and Collaborations 34
    • 7.1.2 Needle-free injection technology manufacturing process value chain 35

8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37

  • 8.1 General Overview 37
    • 8.1.1 Prefilled needle-free injection systems 38
    • 8.1.2 Fillable needle-free injection systems 39

9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41

  • 9.1 General Overview 41
    • 9.1.1 Jet Injectors 42
    • 9.1.2 Transdermal Drug Delivery Systems 43
    • 9.1.3 Inhaler Technology 44

10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46

  • 10.1 General Overview 46
    • 10.1.1 Insulin Delivery 47
    • 10.1.2 Vaccination 48
    • 10.1.3 Pediatric Injections 49
    • 10.1.4 Pain Management 50

11. MARKET INSIGHTS BY INJECTION METHODS 51

  • 11.1 General Overview 51
    • 11.1.1 Powder injections 52
    • 11.1.2 Liquid injections 53
    • 11.1.3 Depot or Projectile Injection 54

12. MARKET INSIGHTS BY SOURCE POWER 55

  • 12.1 General Overview 55
    • 12.1.1 Spring Loaded Jet Injector 56
    • 12.1.2 Gas Powered Jet Injector 57
    • 12.1.3 Battery Powered Jet Injector 58

13. MARKET INSIGHTS BY REGION 59

  • 13.1 General Overview 59
    • 13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60
      • 13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62
      • 13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62
      • 13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63
      • 13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63
      • 13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64
    • 13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64
      • 13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68
      • 13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68
      • 13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69
      • 13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69
      • 13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70
    • 13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70
      • 13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74
      • 13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74
      • 13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75
      • 13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75
      • 13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76
    • 13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76
      • 13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78
      • 13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78
      • 13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79
      • 13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79
      • 13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80

14. COMPETITIVE SCENARIO 81

  • 14.1 Porter's Five forces analysis 81
    • 14.1.1 Bargaining power of Buyer 81
    • 14.1.2 Bargaining power of Supplier 82
    • 14.1.3 The threat of new entrants 82
    • 14.1.4 Availability of Substitute 83
    • 14.1.5 Industry Rivalry 83
  • 14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84

15. COMPANY PROFILES 85

  • 15.1 Antares Pharma, Inc. 85
    • 15.1.1 Key Facts 85
    • 15.1.2 Business Description 85
    • 15.1.3 Key Product/Services Offerings 86
    • 15.1.4 SWOT Analysis 87
    • 15.1.5 Key Financials 87
    • 15.1.6 Recent Developments 89
    • 15.1.7 Funding 89
  • 15.2 Consort Medical 90
    • 15.2.1 Key Facts 90
    • 15.2.2 Business Description 90
    • 15.2.3 Key Product/Services Offerings 91
    • 15.2.4 SWOT Analysis 92
    • 15.2.5 Key Financials 92
    • 15.2.6 Revenue Split 93
    • 15.2.7 Recent Developments 94
  • 15.3 Crossject Societe Anonyme 95
    • 15.3.1 Key Facts 95
    • 15.3.2 Business Description 95
    • 15.3.3 SWOT Analysis 96
    • 15.3.4 Recent Developments 96
    • 15.3.5 Funding 96
  • 15.4 Inovio Pharmaceuticals 97
    • 15.4.1 Key Facts 97
    • 15.4.2 Business Description 97
    • 15.4.3 SWOT Analysis 99
    • 15.4.4 Key Financials 100
    • 15.4.5 Revenue Split 101
    • 15.4.6 Recent Developments 101
    • 15.4.7 Funding 101
  • 15.5 Injex Pharma 102
    • 15.5.1 Key Facts 102
    • 15.5.2 Business Description 102
    • 15.5.3 Key Product/Services Offerings 102
    • 15.5.4 SWOT Analysis 103
  • 15.6 Medical International Technology 104
    • 15.6.1 Key Facts 104
    • 15.6.2 Business Description 104
    • 15.6.3 Key Product/Services Offerings 105
    • 15.6.4 SWOT Analysis 105
    • 15.6.5 Key Financials 106
    • 15.6.6 Recent Developments 107
  • 15.7 Zosano Pharma 108
    • 15.7.1 Key Facts 108
    • 15.7.2 Business Description 108
    • 15.7.3 Key Product/Services Offerings 109
    • 15.7.4 SWOT Analysis 109
    • 15.7.5 Key Financials 110
    • 15.7.6 Recent Developments 111
  • 15.8 Valeritas 112
    • 15.8.1 Key Facts 112
    • 15.8.2 Business Description 112
    • 15.8.3 Key Product/Services Offerings 113
    • 15.8.4 SWOT Analysis 113
    • 15.8.5 Key Financials 114
    • 15.8.6 Revenue Split 115
    • 15.8.7 Recent Developments 115
    • 15.8.8 Funding 115
  • 15.9 3M 116
    • 15.9.1 Key Facts 116
    • 15.9.2 Business Description 116
    • 15.9.3 Key Product/Services Offerings 117
    • 15.9.4 SWOT Analysis 118
    • 15.9.5 Key Financials 118
    • 15.9.6 Revenue Split 119
    • 15.9.7 Recent Developments 120
    • 15.9.8 Funding 120
  • 15.10 PharmaJet 121
    • 15.10.1 Key Facts 121
    • 15.10.2 Business Description 121
    • 15.10.3 Key Product/Services Offerings 122
    • 15.10.4 SWOT Analysis 122
    • 15.10.5 Recent Developments 123
    • 15.10.6 Funding 123

List of Tables

  • FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
  • FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20
  • FIG. 3 Global Needle Free Drug Delivery Device Market 2019-2025 (US$ Million) 21
  • FIG. 4 Facts about Chronic Disease in the US, 2016 25
  • FIG. 5 Frequency of Needle Stick Injuries, by Devices 25
  • FIG. 6 Process for Self-Administration of Medicines (SAMS) 26
  • FIG. 7 Global Top Country, by Start-Up County 2017 29
  • FIG. 8 Global Funding, by Region 2016 & 2017 (US$ billion) 29
  • FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30
  • FIG. 10 Needle-free Injection Technology Manufacturing Process 35
  • FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2018 & 2025 (%) 37
  • FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (US$ Million) 37
  • FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2018 & 2025 (%) 41
  • FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (US$ Million) 41
  • FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2018 & 2025 (%) 46
  • FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 46
  • FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2018 & 2025 (%) 51
  • FIG. 18 Global Needle-Free Drug Delivery Device Market by Injection method, 2018-25 (US$ Million) 51
  • FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2018 & 2025 (%) 55
  • FIG. 20 Global Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Million) 55
  • FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2018 & 2025 (%) 59
  • FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 59
  • FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60
  • FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61
  • FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ≥18 US, 2013-2015 61
  • FIG. 26 Europe % of population over 65 years old, by Country 2017 65
  • FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65
  • FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66
  • FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67
  • FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72
  • FIG. 31 Asia-Pacific Medical Equipment Market US$ Billion (2015-2018) 72
  • FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73
  • FIG. 33 Porter's Five forces analysis of Global Needle-Free Drug Delivery Device 81
  • FIG. 34 Patent count of Smart Drug Delivery System 84
  • FIG. 35 Antares Pharma Inc. SWOT Analysis 87
  • FIG. 36 Key Financials of Antares Pharma Inc. 87
  • FIG. 37 Antares Pharma Inc. Revenue Split, 2018 88
  • FIG. 38 Consort Medical SWOT Analysis 92
  • FIG. 39 Key Financials of Consort Medical 92
  • FIG. 40 Consort Medical Revenue Split, 2017 93
  • FIG. 41 Crossject Societe Anonyme SWOT Analysis 96
  • FIG. 42 Inovio Pharmaceuticals SWOT Analysis 99
  • FIG. 43 Key Financials of Inovio Pharmaceuticals 100
  • FIG. 44 Inovio Pharmaceuticals Revenue Split, 2018 101
  • FIG. 45 Injex Pharma, SWOT Analysis 103
  • FIG. 46 Medical International Technology, SWOT Analysis 105
  • FIG. 47 Key Financials of Medical International Technology 106
  • FIG. 48 Medical International Technology Revenue Split, 2018 107
  • FIG. 49 Zosano Pharma SWOT Analysis 109
  • FIG. 50 Key Financials of Zosano Pharma 110
  • FIG. 51 Valeritas, SWOT Analysis 113
  • FIG. 52 Key Financials of Valeritas 114
  • FIG. 53 Valeritas Revenue Split, 2018 115
  • FIG. 54 3M SWOT Analysis 118
  • FIG. 55 Key Financials of 3M 118
  • FIG. 56 3M Revenue Split, 2018 119
  • FIG. 57 Medtronic Plc SWOT Analysis 122

List of Figures

  • TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (US$ Million) 21
  • TABLE 2 Guidelines of Using Needle Free Devices 26
  • TABLE 3 Examples of Prefilled Needle-Free Devices 37
  • TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (US$ Million) 38
  • TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (US$ Million) 38
  • TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (US$ Million) 41
  • TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (US$ Million) 42
  • TABLE 8 Global Inhaler Technology by Region, 2018-25 (US$ Million) 43
  • TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (US$ Million) 46
  • TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (US$ Million) 47
  • TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (US$ Million) 48
  • TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (US$ Million) 49
  • TABLE 13 Specification of Needle-Free Devices By Injection Methods 51
  • TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (US$ Million) 52
  • TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 52
  • TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (US$ Million) 53
  • TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (US$ Million) 53
  • TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (US$ Million) 55
  • TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (US$ Million) 56
  • TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (US$ Million) 57
  • TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (US$ Million) 61
  • TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 61
  • TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Million) 62
  • TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 62
  • TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Million) 63
  • TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Million) 67
  • TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 67
  • TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Million) 68
  • TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 68
  • TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Million) 69
  • TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 70
  • TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Million) 73
  • TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 73
  • TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (US$ Million) 74
  • TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 74
  • TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (US$ Million) 75
  • TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 76
  • TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (US$ Million) 77
  • TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (US$ Million) 77
  • TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (US$ Million) 78
  • TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (US$ Million) 78
  • TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Million) 79
  • TABLE 43 Antares Pharma Inc. Key Facts 84
  • TABLE 44 Product segmentation of Antares Pharma Inc. 85
  • TABLE 45 Antares Pharma, Inc. Growth Strategy 85
  • TABLE 46 Revenue Split 87
  • TABLE 47 Consort Medical Key Facts 89
  • TABLE 48 Product segmentation of Consort Medical 90
  • TABLE 49 Consort Medical Growth Strategy 90
  • TABLE 50 Crossject Societe Key Facts 94
  • TABLE 51 Product segmentation of Crossject Societe Anonyme 94
  • TABLE 52 Crossject Societe Anonyme Growth Strategy 95
  • TABLE 53 Inovio Pharmaceutical Key Facts 96
  • TABLE 54 Product segmentation of Inovio Pharmaceuticals 97
  • TABLE 55 Inovio Pharmaceuticals Growth Strategy 98
  • TABLE 56 Injex Pharma Key Facts 101
  • TABLE 57 Product segmentation of Injex Pharma 101
  • TABLE 58 Injex Pharma Growth Strategy 102
  • TABLE 59 Medical International Technology Key Facts 103
  • TABLE 60 Product segmentation of Medical International Technology 104
  • TABLE 61 Medical International Technology Growth Strategy 104
  • TABLE 62 Revenue Split 106
  • TABLE 63 Zosano Pharma Key Facts 107
  • TABLE 64 Product segmentation of Zosano Pharma 108
  • TABLE 65 Zosano Pharma Growth Strategy 108
  • TABLE 66 Valeritas Key Facts 111
  • TABLE 67 Product segmentation of Valeritas 112
  • TABLE 68 Valeritas Growth Strategy 112
  • TABLE 69 3M Key Facts 115
  • TABLE 70 Product segmentation of 3M 116
  • TABLE 71 3M Growth Strategy 116
  • TABLE 72 PharmaJet Key Facts 120
  • TABLE 73 Product segmentation of PharmaJet 121
  • TABLE 74 Pharmajet Growth Strategy 121
Back to Top